Unigene to Present at the 11th Annual Needham Healthcare Conference

BOONTON, N.J., March 29, 2012 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, announced today that David Moskowitz, Chief Financial Officer, will present a corporate overview at the 11th Annual Needham Healthcare Conference 2012 in New York, NY.  Mr. Moskowtiz's presentation is scheduled to begin at 2:40 p.m. ET on Wednesday, April 4, 2012.

A live webcast of the presentation will be available by visiting the Investors and Media section under the Events tab of the Unigene web site, http://www.unigene.com. Participants should allow 10 minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's web site for 30 days.

About Unigene Laboratories, Inc.

Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform. Peptelligence™ encompasses extensive intellectual property covering drug delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence™ assets include proprietary oral and nasal peptide drug delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.

Investor Contact:
Unigene Laboratories, Inc.
Jenene Thomas
VP, Investor Relations and Business Administration
973-265-1107
jthomas@unigene.com

Media Contact:
Tiberend Strategic Advisors, Inc.
Jason Rando / Andrew Mielach
212-827-0020
jrando@tiberend.com  / amielach@tiberend.com

SOURCE Unigene Laboratories, Inc.

RELATED LINKS
http://www.unigene.com